The 3-thia fatty acid tetradecylthioacetic acid (TTA) 
INTRODUCTION
The sulphur-containing 3-thia fatty acid tetradecylthioacetic acid (TTA) decreases serum triacylglycerol and serum cholesterol when fed to rats [1] . It also induces a series of fatty-acidmetabolizing enzymes in the liver, including the peroxisomal ,f-oxidation and the microsomal fatty acid w-hydroxylating enzymes [1, 2] .
The sulphur atom in the 3-position blocks normal fl-oxidation of these acids. They are thus metabolized by w-oxidation and excreted in the urine as short-chain dicarboxylic sulphoxides [2, 3] . In isolated hepatocytes, the 3-thia fatty acids are taken up and incorporated into phospholipids and triacylglycerol at rates which may even exceed those of normal fatty acids, presumably because normal oxidation is blocked [4] .
In Morris 7800 C1 hepatoma cells TTA inhibits cell growth and increases the peroxisomal acyl-CoA oxidase (ACO) activity and mRNA level [5] [6] [7] . Dexamethasone potentiates and insulin antagonizes these effects of TTA [5, 6] . The increase in ACO mRNA level by TTA involves both transcriptional effects and mRNA stabilization [6] . These results suggest that the 7800 Cl Morris hepatoma cells represent an interesting model for studying the metabolism of 3-thia acids and the influence of dexamethasone and insulin on this.
In the present study we have investigated how the induction of wo-hydroxylation activity of 3- [5] [6] [7] 9] . The cells were treated for 7 days, at which time there is a steady response of the cells to these compounds. 25 ,uM) and/or insulin (0.4 1sM). The incubation was stopped by removing the medium and washing the cells with 2 x 1.0 ml of 0.15 M KCI/20 mM Hepes buffer (pH 7.4). The wash phases were combined with the medium. The dishes were then scraped with 3.0 ml of the same buffer and routinely sonicated for 15 s with a Sonicator cell disruptor.
To samples of the medium and cell suspensions (450 ,1), 4 M HC104 (100 ,u) was added. They were centrifuged to remove lipids and protein and a sample of the acid-soluble phase counted for radioactivity. Other samples of the medium and cell suspensions (2.0 ml) were extracted with butan-1-ol (1.0 ml), as described previously [4] , and a sample was counted for radioactivity. The butan-l-ol phase was then removed under a stream of nitrogen, and the residue was resolved in chloroform and stored at -20°C for subsequent t.l.c. The recovery of radioactivity was close to 100%.
The butanol-extracted lipids were separated by chromatography on silica-gel aluminium t.l.c. plates with hexane/diethyl ether/acetic acid (35:15:1, by vol.), and the subclasses of phospholipids were separated on t.l.c. using a mobile phase of chloroform/methanol/acetic acid/water (65:25:4:4, by vol.) as described previously [4] .
Fatty acid composition of cell lipids
The butanol extracts of two dishes were combined, and to each pooled sample was added 50,g of L-a-diheptadecanoyl phosphatidylcholine as internal standard. The butanol was removed under a stream of nitrogen and the residues were dissolved in chloroform. Each sample was then subjected to anion-exchange chromatography on bonded-phase columns, as described by Kaluzny et al. [10] , to yield non-esterified fatty acid, triacylglycerol and phospholipid fractions. The phospholipid fraction was hydrolysed in methanolic 15 % (w/v) KOH for 45 min at 65°C, and the non-esterified fatty acids were liberated by acidification with 6 M HCl, and then extracted with hexane. The fatty acids were then converted into picolinyl esters as described by Christie [11] and separated by capillary gas chromatography on a 50 m BPI column (0.22 mm internal diam.; S.G.E. International, Ringwood, Victoria, Australia) using a Carlo Erba Model 4150 gas chromatograph fitted with a flame ionization detector and a Shimadzu C-R6A Chromatopac electronic integrator. After splitless sample injection, the column was initially held for 3 min at 40°C, then programmed to increase at 40°C/min to 140°C, held there for 3 min, then programmed to increase at 40 'C/min to 280 'C. Amounts of TTA and other fatty acids were calculated by using the internal standard method. The amount of TTA integrated proved to be only half of the actual amount of the3-thia acid. This was corrected for.
The identity of the TTA peak was verified by subjecting parallel samples to gas chromatography-mass spectrometry on a Shimadzu GCMS QP-2000 instrument equipped with a 40 m DBl column (0.18 mm internal diam.; J&W Scientific, Folsom, CA, U.S.A.).
co-Hydroxylation and sulphur oxygenation of [1-"C1CDTA
The sonicated cell suspensions were incubated as described. previously [12] . The 2.0 ml, the temperature 37°C and the incubation time 15.5 min. The incubation was started with DTA and stopped with 0.8 ml of acetonitrile, and cellular protein was removed by centrifugation. The radioactive products were analysed by h.p.l.c. using a reverse-phase column, Supelcosil LC-18 (Supelco, Bellefonte, PA, U.S.A.) connected to a Raytest Ramona 5LS liquidscintillation counter (Isotopenmessgerate, Straubenhardt, Germany). The products were separated as described previously [2] .
o9-Hydroxylatlon of [1-14C]Iauric acid
The cells were treated and incubated as above, except that the incubation mixture contained 25 mM Hepes, pH 7.4, and 60 /ZM [1-14C] lauric acid (3.6 ,uCi/1mol). The incubation was stopped with 0.8 ml acetonitrile. To separate cv-and (cv-I)-hydroxylated products, the acetonitrile was evaporated under nitrogen and 0.8 ml of methanol was added before analysis of the products on h.p.l.c., using the same column and liquid scintillator as above. The radioactive products of lauric acid were separated with an isocratic gradient of methanol/acetic acid/water (100: 1: 100, by vol.) at a flow rate of 0.8 ml/min essentially as described previously [13] .
Other assays DNA was measured as described previously [14] .
ACO (palmitoyl-CoA oxidase) was measured as described by Small et al. [15] and modified as previously described [7] . The enzymatic activity was determined in 0.1 M Tris buffer, pH 8.5, including BSA (0.6 %) and FAD (16 ,uM) , and omitting NN'-dimethylformamide and aminotriazole.
Total phospholipids were measured as lipid P [16] .
Statistics
Student's t test was used for statistical analysis.
RESULTS
Induction of the w9-hydroxylatlon pathway in the hepatoma cells When measuring c-hydroxylation and sulphur oxygenation activity of the 3-thia fatty acids in the Morris 7800 Cl hepatoma cells, DTA was used as substrate, because we have already established a h.p.l.c. system for separation of the initial metabolites of DTA [2] . TTA gives similar results. In the Morris 7800 C1 hepatoma cells [1-14C]DTA is converted into both sulphur-oxygenated and w-hydroxylated products in the presence of NADPH (see Figure 1 for the structures of the thia-substituted fatty acids and their metabolites). The sulphuroxygenation activity was approx. 15 times greater than the whydroxylation activity (Table 1 ). In contrast, the two activities are about equal in rat liver microsomes [2] . In isolated rat hepatocytes the activities of w-hydroxylation and sulphur oxygenation of DTA are equal, and are approx. 6 times more and 2.5 times less, respectively, compared with the hepatoma cells (results not shown).
Pretreating the cells for 7 days with TTA (80 pM) did not significantly increase the total w-hydroxylation of DTA (Table   1 ). In contrast, the ACO activity increased 6.5-fold. Pretreating the cells with TTA and dexamethasone (0.25 ,uM) in combination significantly increased (7-fold) the w-hydroxylation of DTA and, as shown previously [6] , dexamethasone acted synergistically with TTA on the ACO activity (increased 13-fold) ( Table 1) . Insulin (0.4 ,uM) antagonized the inductive effect of TTA and dexamethasone on both the )-hydroxylation activity and the ACO activity. Dexamethasone alone significantly increased (2.4-fold) the w-hydroxylation activity, whereas the ACO activity was unchanged ( Table 1) .
The sulphur oxygenation of DTA was moderately decreased after treatment with TTA ( Table 1) .
The preferred substrate for the cytochrome P-450IVA1 enzyme is lauric acid [17] . Figure 2 shows that the total ohydroxylation of lauric acid varied in the same way as the total wo-hydroxylation of DTA. It did not increase in cells treated with TTA, as opposed to the ACO activity. Treating the cells with TTA and dexamethasone in combination increased the whydroxylation activity, with a maximum after 3 days.
The response of the w-hydroxylation enzyme to pretreatment with TTA alone varied with the age of the stem culture (results not shown). In young stem cultures the w-hydroxylation was more responsive to TTA alone, but in old cultures dexamethasone was required in addition to induce the enzyme, as shown in that TTA increased the uptake of this fatty acid. Palmitic acid (C16:0) and vaccenic acid (C18.1 (n-7)) were significantly decreased (Table 3) . Treating the cells with 80,M palmitic acid also surprisingly decreased the amount of this fatty acid in the phospholipid fraction, but a significant increase in palmitoleic acid (C16:l(n7)) was found ( Table 3 ). The absolute amount of fatty acids in the phospholipid fraction was nearly doubled in the TTA-treated cells (Table 3) , indicating increased phospholipid synthesis. This was confirmed by measurement of the phospholipid content in TTA-treated cells. The amount of phospholipids was increased after 7 days with TTA in the medium (Table 4) . The chromatogram from the cells treated with TTA (results not shown) shows the presence of an unidentified peak. This is presumably a metabolite of TTA, since it was not found in the phospholipid fraction ofcells treated with standard medium. The retention time suggests monounsaturated TTA.
Metabolism of [1_14C]TTA
We also studied the rate of incorporation of [1-14C]TTA (80 FM) in shorter experiments (17 h). T.l.c. showed that [1-14C]TTA was incorporated into phospholipids, di-and tri-acylglycerol (Table  5 ). Most of the activity was found in the phospholipid fraction (90 %), and very little was found incorporated into di-and triacylglycerol (1-2 %). In phospholipids most of the activity was found as phosphatidylcholine (approx. 60 %) and phosphatidylethanolamine (approx. 22%). No sulphur-oxygenated metabolites were found in the lipid fraction from the cells (results not shown). In the medium, 9% of the added radioactivity was recovered as acid-soluble metabolites, presumably dicarboxylic sulphoxides (not identified). (Table 3 ). The medium was relatively rich in linoleic acid (Table 2) . It is therefore evident Incorporation of [1_'4CJTTA into triacylglycerol Table 5 shows that pretreatment of the cells with dexamethasone (0.25 FM) increased the incorporation of labelled TTA into both phospholipids and into di-and tri-acylglycerol. Most of the labelled triacylglycerol formed in the dexamethasone-treated cells was excreted into the medium. The excretion in these cells was increased 4-5-fold. In contrast, when TTA (80 FM) was present with dexamethasone before incubation with labelled TTA, the labelled triacylglycerol formed was retained in the cell.
Pretreatment of the cells with insulin (0.4 FM) selectively increased incorporation of labelled TTA into triacylglycerol, without any significant effect on total uptake of TTA into the cells (Table 5 ). The labelled triacylglycerol formed in the insulin- [5] . With insulin in the medium the growth rate is even close to normal [5] .
The accumulation of TTA-containing phospholipids in the hepatoma cells (Table 3) is probably a result of a slow breakdown of the 3-thia fatty acids, due to the poor w-hydroxylation activity in these cells. [21] [22] [23] [24] . In this study, TTA decreases both the increased synthesis of TTAlabelled cellular triacylglycerol found with insulin and the increased secretion of TTA-labelled triacylglycerol found with dexamethasone ( Table 5 ).
The increased synthesis and secretion of TTA-labelled triacylglycerol found with dexamethasone and the increased synthesis of TTA-labelled cellular triacylglycerol found with insulin (Table  5 ) are in agreement with several other studies which show the same effects of dexamethasone [25] [26] [27] and insulin [28] [29] [30] [31] [32] [33] [34] .
In conclusion, due to the massive incorporation of TTA into phospholipids in the Morris 7800 Cl hepatoma cells, the cells are evidently a good model system for studying the effects of this on, e.g., the signal-transduction pathway involving phospholipid breakdown. The present results also show that the hepatoma cells are of interest for studying the influence of insulin and dexamethasone on the triacylglycerol-lowering effects of hypolipidaemic compounds.
